1. Home
  2. PHUN vs ELOX Comparison

PHUN vs ELOX Comparison

Compare PHUN & ELOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phunware Inc.

PHUN

Phunware Inc.

HOLD

Current Price

$2.11

Market Cap

39.3M

Sector

Technology

ML Signal

HOLD

Logo Eloxx Pharmaceuticals Inc. Common Stock

ELOX

Eloxx Pharmaceuticals Inc. Common Stock

N/A

Current Price

$17.43

Market Cap

41.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
PHUN
ELOX
Founded
2009
N/A
Country
United States
United States
Employees
N/A
7
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
39.3M
41.0M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
PHUN
ELOX
Price
$2.11
$17.43
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$7.25
N/A
AVG Volume (30 Days)
94.7K
58.2K
Earning Date
05-14-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
39.36
N/A
EPS
N/A
N/A
Revenue
$30,883,000.00
N/A
Revenue This Year
$89.86
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
15.57
N/A
52 Week Low
$1.56
$10.00
52 Week High
$3.13
$15.00

Technical Indicators

Market Signals
Indicator
PHUN
ELOX
Relative Strength Index (RSI) 52.18 56.47
Support Level $1.79 $10.74
Resistance Level $2.28 $14.37
Average True Range (ATR) 0.09 1.54
MACD -0.01 0.24
Stochastic Oscillator 29.17 85.22

Price Performance

Historical Comparison
PHUN
ELOX

About PHUN Phunware Inc.

Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services. Development services for customers who wish to have a customized application experience; and In-app advertising services for mobile audience building, user acquisition, application discovery, audience engagement and monetization.

About ELOX Eloxx Pharmaceuticals Inc. Common Stock

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.

Share on Social Networks: